---
figid: PMC9351107__12943_2022_1629_Fig3_HTML
figtitle: 'Targeting KRAS mutant cancers: from druggable therapy to drug resistance'
organisms:
- NA
organisms_ner:
- Danio rerio
- Homo sapiens
pmcid: PMC9351107
filename: 12943_2022_1629_Fig3_HTML.jpg
figlink: /pmc/articles/PMC9351107/figure/Fig3/
number: F3
caption: Overview of MAPK/PI3K signaling pathway and mechanisms of resistance to KRAS
  inhibitors. a Schematic representation of KRAS cycling and signaling pathway. b
  Mechanisms of resistance to KRAS inhibitors. Acquired mutations concerning the drug-binding
  sites and feedback activation of KRAS upstream and downstream signaling pathways
  favor drug resistance to KRAS mutant inhibitors
papertitle: 'Targeting KRAS mutant cancers: from druggable therapy to drug resistance.'
reftext: Chunxiao Zhu, et al. Mol Cancer. 2022;21:159.
year: '2022'
doi: 10.1186/s12943-022-01629-2
journal_title: Molecular Cancer
journal_nlm_ta: Mol Cancer
publisher_name: BioMed Central
keywords: KRAS mutations | Druggable | Resistance | Combination therapy
automl_pathway: 0.8132679
figid_alias: PMC9351107__F3
figtype: Figure
redirect_from: /figures/PMC9351107__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9351107__12943_2022_1629_Fig3_HTML.html
  '@type': Dataset
  description: Overview of MAPK/PI3K signaling pathway and mechanisms of resistance
    to KRAS inhibitors. a Schematic representation of KRAS cycling and signaling pathway.
    b Mechanisms of resistance to KRAS inhibitors. Acquired mutations concerning the
    drug-binding sites and feedback activation of KRAS upstream and downstream signaling
    pathways favor drug resistance to KRAS mutant inhibitors
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - kras
  - gap43
  - sos1
  - ptpn11a
  - mtor
  - braf
  - si:dkey-222f8.3
  - KRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - RASA1
  - RGS6
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - SOS1
  - PTPN11
  - MTG1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - DUSP5
  - DUSP1
  - DUSP2
  - DUSP3
  - DUSP4
  - DUSP6
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - SPRY1
  - SPRY2
  - SPRY3
  - SPRY4
---
